Boeing rides every trade deal as forced jet purchases get bundled into bilateral agreements.
GDP-on-blockchain push and commercial space commerce reorg signal real-economy data and satellite tailwinds.
Chinese EV/battery overcapacity and dumping keep crushing Western automakers like Volkswagen.
Japan trade deal funds US nuclear and infrastructure with 50/50 then 90/10 cashflow to America; sets up a US nuclear build cycle.
MFN drug pricing crushes US branded prices but volume access (Ozempic/Mounjaro at $149) and tariff relief reset pharma economics.
Merck giving its top drug to Medicaid/Medicare for free signals severe MFN margin pressure on big pharma.
Korea's reset trade terms drove its market up 70%; the deal-makes-them-stronger thesis favors Korean equities.
Micron is breaking ground on tens of billions in US fabs, a beneficiary of CHIPS plus tariff-driven reshoring.
US heading to 5-6% GDP growth in 2026 on construction surge plus rate cuts; bullish broad US equities.
TSMC's US fab hitting China-level 4nm yields plus a $165B+ expansion makes it America's onshore chip backbone.
NVIDIA gets China revenue back via H200 export licenses; the 25% tariff is a throwaway, so volume upside is real.
US government owns 10% of Intel and is steering CHIPS money to it; equity backstop limits downside.